High Throughput Gel Shifts

To determine whether a given transcription factor activity is present in a sample, you need look no farther than the standard electrophoretic mobility shift assay (EMSA). In an EMSA, researchers mix a radioactively labeled DNA probe with a protein extract and run the entire reaction on a nondenaturing polyacrylamide gel. Because the protein-bound probe will migrate more slowly than a free probe, the experiment is described as a "gel shift." Unfortunately, the gel shift is a cumbersome way to pro

Written byJeffrey Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Using the array is simple. Researchers mix protein extracts (e.g., nuclear extracts [25 µg]), with prelabeled probe mix supplied by Panomics. This mix contains all of the cis elements the MYRIA array can currently detect, each of which was selected because of its wide representation in published literature. After an incubation period, the investigator resolves the free and bound complexes on an agarose gel and purifies the bound complex. Then, the user interrogates the MYRIA array with this purified probe, on which each element is spotted in duplicate and at two separate concentrations.

Currently, the system is supplied with biotin-labeled probes and nylon membrane-based arrays. Panomics is in the process of developing a glass slide-based system, using fluorescently labeled probes to allow for dual-color analyses. This feature would allow researchers to compare the effect of drug treatment on a single cell line, for example. According to Jason Li, Panomics president ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies